Navigation Links
Combined treatment extends life expectancy for lung cancer patients

Combining thermal ablation with radiation therapy extends average life expectancy and decreases recurrences of tumors in patients who have early stages of inoperable lung cancer, according to researchers at Rhode Island Hospital.

In a retrospective study looking at patients over seven years, the median survival rate at three years increased from 20 months after radiation alone to 42 months when thermal ablation was followed by radiation for treatment of non-small-cell lung cancer. The results are published in the July issue of the Journal of Vascular and Interventional Radiology.

"This study shows us that even patients who are not eligible for surgery can still get very good results," says senior author Damian Dupuy, MD, director of ultrasound at Rhode Island Hospital and professor of diagnostic imaging at Brown Medical School, both in Providence, RI. "By combining thermal ablation and radiation, you have a better chance of survival than with either treatment alone."

With radiation alone, overall survival rates were as follows:

one year ?57 percent
two years ?36 percent
three years ?21 percent

With thermal ablation and radiation, they were significantly higher:

one year ?87 percent
two years ?70 percent
three years ?57 percent

Surgery is the standard treatment for lung cancer. However, only one-third of patients with early stage lung cancer qualify for surgery because of other underlying medical conditions. Radiation therapy has long been used for inoperable lung cancer, and more recently, doctors have used radiofrequency ablation (RFA) and microwave ablation, processes that heat tumors to destroy them. For patients who cannot have surgery or radiation, the median survival is about one year.

In this study, researchers looked retrospectively at 41 patients treated over seven years with thermal ablation (RFA or microwave ablation) and either standard radiation therapy or b
'"/>

Source:Lifespan


Page: 1 2 3

Related biology news :

1. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
2. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
3. Protein discovery could unlock the secret to better TB treatment
4. Topical treatment shown to inhibit HIV and herpes simplex virus infection
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. Researchers add new tool to tumor-treatment arsenal
7. Potential treatments for neurofibromatosis
8. Nanoparticles offer new hope for detection and treatment
9. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
10. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
11. New understanding of DNA repair may pave way to cancer treatments

Post Your Comments:
(Date:11/24/2009)..., What constitutes fish food is a matter of deba... that fish get almost 50 percent of their carbon f...nk between the terrestrial and aquatic ecosystems....ngton shows this is not likely to be true. Algae p...ic life, according to research published this week...
(Date:11/23/2009)..., CINCINNATINew research presents strong evidence...ure to both outdoor traffic-related pollution and ...ngs than one or the other exposure alone. , En... Cincinnati (UC) College of Medicine have shown th...-related particles and indoor endotoxin during ear...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ...rding to a new paper produced by a research team l...ronto Scarborough,s vice-principal for research an... biology at the St. George campus. , Capitaliz... the poplar tree, the research team examined how p...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2LA BioMed to honor Emil D Kakkis M D Ph D and LA County Supervisor Don Knabe 58426 1LA BioMed to honor Emil D Kakkis M D Ph D and LA County Supervisor Don Knabe 58426 2Clemson researchers study energy savings with electric cars and IntelliDrive technology 10145 1Clemson researchers study energy savings with electric cars and IntelliDrive technology 10145 2Dr Richard Feinman to speak on the science of diabetes and diet on Oct 2 10142 1
...,AWRE), a leading supplier of broadband technology...results for its fourth quarter ended December 31,2...e $6.8 million, an increase,of 5% compared to $6.4...ar,ended December 31, 2007, revenues increased 10%...he year ended December 31, 2006., The Company rep...
...patients who need a ventilator to breathe face a h..., is exceedingly difficult to diagnose because a p...ry test results and masks pneumonia,s symptoms a ...tment. , Using gene chip technology, scientists a...Louis demonstrate for the first time they can dist...
... key source of water for millions of people in the...f climate changes as expected and future water usa...chers at Scripps Institution of Oceanography, UC S...ake Powell, the Colorado River system has no buffe...gh an unusually dry year, or worse, a sustained dr...
Other Biology News:Aware, Inc. Reports Fourth Quarter and 2007 Financial Results 2Aware, Inc. Reports Fourth Quarter and 2007 Financial Results 3Aware, Inc. Reports Fourth Quarter and 2007 Financial Results 4Aware, Inc. Reports Fourth Quarter and 2007 Financial Results 5Aware, Inc. Reports Fourth Quarter and 2007 Financial Results 6Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness 2Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness 3Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness 4Lake Mead could be dry by 2021 2Lake Mead could be dry by 2021 3
(Date:11/24/2009)...VIK,Iceland,November24/PRNewswire-FirstCall/--deCO...provalofallofits,"firstday"motionsbytheU.S.Bankrup...urt").deCODElastweekfiledavoluntarypetitionfor,rel...ththe,BankruptcyCourt. , Theordersissuedbythe...itsbusinessduringtheChapter11proceedings.Inparticu...
(Date:11/24/2009)...EO,Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,...edondevelopingandcommercializingnovelpainmanagemen...entandChiefExecutiveOfficer,isscheduledtopresentat...heldDecember1-2,2009atTheNewYorkPalaceHotelinNewYo...iefFinancialOfficer,willbeavailabletorespondtoques...
(Date:11/24/2009)...E,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.announc...Authority(OPDA)wererecentlyawarded$2millionbyWashi...ERB)inaprivate/publicpartnershiptoconstructthestat...unty,WA. ,, "Thisinvestmentwillsignificantlyspe...njobstoLincolnCounty,"saidBlueMarbleEnergyCEOKelly...
(Date:11/24/2009)...yefficacyendpointhasbeenmetforpatientswithadvanced...CITY,Nov.24/PRNewswire-FirstCall/-AEternaZentarisI...opharmaceuticalcompanyfocusedonendocrinetherapyand...ase2studywithitstargetedcytotoxicpeptideconjugate,...ecurrentendometrialcancer.Inapersonalizedhealthcar...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...gy Expert to Speak, RESTON, Va., Oct. 23 PRA Int...r. Ute Berger, the company,s senior,director of th...nd,hematology, will present a one-hour audioconfer...ology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST....ls," Dr. Berger will,recommend ways to mitigate ri...
..., Calif., Oct. 23 InVitria has released data,that...for cell culture,media outperforms transferrin and...sferrin costs. Because Lacromin is produced in a c... productivity and safety over,animal-derived alter...,addition data has shown that Lacromin significant...
..., Mass., Oct. 23 OmniSonics Medical,Technologies,... use in the,treatment of vascular disease, today a...e position of Vice President, Sales. Mr. McNerney...nce,building high-performance sales teams in the m... with Datascope Corporation, where, as Vice,Presid...
Other Biology Technology:PRA International to Present Audioconference on Oncology Research - Nov. 8 2InVitria's Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin 2OmniSonics Appoints Sean McNerney as Vice President, Sales 2
MSC.12 class II safety cabinet (Type A1) - CE Marked (230V / 50Hz) from Thermo Scientific
Kit for BASE20/50 units from Wave Biotech now part of GE Healthcare
...HM-4000 Multidizer is designed with a variety of m...- all in one unit. Shake, rock, roll and rotate mo...rtments allow for hybridization and blotting proce... motion , The upper chamber uses a roller actio...
...A sleek design loaded with class-leading features,...to ensure that your work is safe and consistent ev...w 1400 Series reduces power consumption by as much...ds of dollars over the life of the cabinet. Multi...
Biology Products: